lorazepam has been researched along with Symptom Cluster in 15 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Excerpt | Relevance | Reference |
---|---|---|
" Intravenous lorazepam was rapidly effective in reversing the catatonia and attendant symptoms." | 7.66 | Intravenous lorazepam in neuroleptic-induced catatonia. ( Cassem, NH; Fricchione, GL; Hobson, D; Hooberman, D, 1983) |
" The syndrome resolved within a few days of stopping haloperidol and initiation of lorazepam." | 3.78 | Neuroleptic-induced catatonia in two hospitalized patients. ( Gugger, JJ; Saad, M; Smith, C, 2012) |
" Intravenous lorazepam was rapidly effective in reversing the catatonia and attendant symptoms." | 3.66 | Intravenous lorazepam in neuroleptic-induced catatonia. ( Cassem, NH; Fricchione, GL; Hobson, D; Hooberman, D, 1983) |
" Ironically, chronic use of cannabis can result in paradoxical effects, including a condition known as cannabinoid hyperemesis syndrome." | 2.61 | Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting. ( Forest, CP; Smith, TN; Walsh, A, 2019) |
"Concerning the management of catatonia in patients with schizophrenia, for whom first-line benzodiazepines are often insufficient, certain atypical antipsychotics such as clozapine or quetiapine appear efficient." | 2.53 | Catatonic syndrome: From detection to therapy. ( Callery, G; Dollfus, S; Lebain, P; Madigand, J, 2016) |
" The acute kidney injury was treated by administration of intravenous fluid." | 1.48 | [A Lot of Hot Steam: the Cannabinoid Hyperemesis Syndrome]. ( Gericke, M; Hartmann, D, 2018) |
"lorazepam t." | 1.25 | Treatment of 'brain fag' syndrome. ( Anumonye, A, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 7 (46.67) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Brown, JM | 1 |
Wilsey, MJ | 1 |
Dhana, L | 1 |
Lonsdale, H | 1 |
Gericke, M | 1 |
Hartmann, D | 1 |
Smith, TN | 1 |
Walsh, A | 1 |
Forest, CP | 1 |
Nair, AG | 2 |
Shah, BR | 1 |
Gandhi, RA | 1 |
Madigand, J | 1 |
Lebain, P | 1 |
Callery, G | 1 |
Dollfus, S | 1 |
Miller, MA | 1 |
Kummerow, AM | 1 |
Mgutshini, T | 1 |
Danivas, V | 1 |
Behere, RV | 1 |
Varambally, S | 1 |
Rao, NP | 1 |
Venkatasubramanian, G | 1 |
Gangadhar, BN | 1 |
Gugger, JJ | 1 |
Saad, M | 1 |
Smith, C | 1 |
Honderick, T | 1 |
Williams, D | 1 |
Seaberg, D | 1 |
Wears, R | 1 |
Wheless, JW | 1 |
Madugula, A | 1 |
Chandrasekaran, R | 1 |
Rakesh, G | 1 |
Wehrschuetz, M | 1 |
Simbrunner, J | 1 |
Enzinger, C | 1 |
Ebner, F | 1 |
Fricchione, GL | 1 |
Cassem, NH | 1 |
Hooberman, D | 1 |
Hobson, D | 1 |
Dubnitskaia, EB | 1 |
Basov, AM | 1 |
Anumonye, A | 1 |
4 reviews available for lorazepam and Symptom Cluster
Article | Year |
---|---|
Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting.
Topics: Acute Disease; Antiemetics; Cannabinoids; Haloperidol; Humans; Lorazepam; Nausea; Syndrome; Vomiting | 2019 |
Catatonic syndrome: From detection to therapy.
Topics: Adolescent; Adult; Catatonia; Child; Humans; Hypnotics and Sedatives; Lorazepam; Psychiatric Status | 2016 |
Othello syndrome. Preventing a tragedy when treating patients with delusional disorders.
Topics: Antipsychotic Agents; Combined Modality Therapy; Commitment of Mentally Ill; Cooperative Behavior; D | 2010 |
Acute management of seizures in the syndromes of idiopathic generalized epilepsies.
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Clonazepam; Comorbidity; Drug Administration Sche | 2003 |
2 trials available for lorazepam and Symptom Cluster
Article | Year |
---|---|
A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes.
Topics: Acute Disease; Adult; Angina Pectoris; Anti-Anxiety Agents; Cocaine; Drug Therapy, Combination; Fema | 2003 |
[Use of phenazepam in the treatment of neurotic conditions].
Topics: Adult; Affective Symptoms; Anti-Anxiety Agents; Benzodiazepines; Chemical Phenomena; Chemistry; Clin | 1978 |
9 other studies available for lorazepam and Symptom Cluster
Article | Year |
---|---|
Acute Treatment of Adolescent Cannabinoid Hyperemesis Syndrome With Haloperidol, Lorazepam, and/or Capsaicin: A Single Institution Case Series.
Topics: Adolescent; Adult; Cannabinoids; Capsaicin; Child; Haloperidol; Humans; Lorazepam; Nausea; Syndrome; | 2023 |
[A Lot of Hot Steam: the Cannabinoid Hyperemesis Syndrome].
Topics: Abdominal Pain; Acute Kidney Injury; Adult; Combined Modality Therapy; Fluid Therapy; Humans; Loraze | 2018 |
Seeing the unseen: Charles Bonnet syndrome revisited.
Topics: Aged; Amines; Awareness; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; H | 2015 |
Electroconvulsive therapy in the treatment of delirious mania: a report of 2 patients.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Catatonia; Delirium; Electroconvulsive Therapy; Fema | 2010 |
Neuroleptic-induced catatonia in two hospitalized patients.
Topics: Adult; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Hospitalization; | 2012 |
Homatropine and psychosis in Weill-Marchesani syndrome.
Topics: Abnormalities, Multiple; Adolescent; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Eye | 2006 |
[Hemiballism-hemichorea syndrome].
Topics: Anti-Dyskinesia Agents; Brain Diseases; Cerebrovascular Circulation; Chorea; Drug Therapy, Combinati | 2007 |
Intravenous lorazepam in neuroleptic-induced catatonia.
Topics: Adult; Aged; Antipsychotic Agents; Catatonia; Female; Haloperidol; Humans; Injections, Intravenous; | 1983 |
Treatment of 'brain fag' syndrome.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Depression; Humans; Lorazepam; Male; Nige | 1975 |